Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Health 32 > HIV > Flashcards

HIV Flashcards

1
Q

HIV-1 genome is made up of structural and non structural genes. What do non structural genes control?

A

replication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

where is the envelope around the virus derived from?

A

own cell membranes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

large protein nuclear capsid structure inside the vireon is produced from what gene?

A

gag gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the 2 main cellular targets for hiv?

A

cd4 lymphocytes and macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

where are cd4 lymphocytes localised ?

A

lymph nodes, GIT, other tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

where are macrophages distributed?

A

all tissues and lymphatic system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the role of cd4 lymphocytes?

A

global immune helper cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the role of macrophages?

A

phagocytosis and presenting foreign antigens within lymph nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What forms the trimer of receptors when viruses reach the surface of CD4 cells?

A

CCR5

CXCR4

CD4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

some ppl have deletion in CCR5 so this means…

A

theyre naturally resistant to HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

name 2 co receptors in close proximity to cd4 receptors that allow for hiv binding and virus entry?

A

CCR5 and CXCR4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

as the gp41 and gp20 from the virus binds with cd4 receptors what happens, to allow for binding ?

A

conformational change to gp20 that allows interaction with CCR5, fusion takes place

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

post fusion, virus enters and nucelocapsid is within cell. Virus moves towards nuclus via microtubules in the cytoplasm. During this process, what enzyme starts to become active in the nucleo capsid?

A

reverse transcriptase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

when the reverse transcriptase and RNAse H enzymes come into contact with the nucleus what process is commenced?

A

proviral dna synthesis and viral RNA digestion
..
so single RNA strand becomes RNA w a DNA template, RNA then degraded down -> another strand of DNA formed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

when the nucelocapsid breaks down which dna is available at the nuclear pore?

A

proviral dsDNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

segments of proviral dsDNA is bounded to integrase enzyme. What is the role of this enzyme?

A

cuts proviral dsDNA, finds cellular dna and inserts proviral dna into our double stranded dna

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

post integration proviral dna is inserted into our dna. proviral dna may remain dormant and later be reactivated via cellular transcription pathways.

If reactivated, what is generated from cellular dna?

A

viral mRNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

true or false: viral rna is looped and spliced to different lengths?

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is the role of the cell protein TAT?

A

directs viral mrna to leave nucleus via nuclear pores

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what different things can happen to viral mrna when it leaves the nucleus?

A

some goes to ribosomes and used as templates for hiv protein synthesis like gag and some form stable dimer of 2 copies as new viral genome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what causes infected cell surfaces to start to bulge?

A

new viral proteins and gag pack together with viral genome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

once the surface of an infected cell membrane starts to bulge, proteins are recruited and pull together the virion and protease enzymes. What process do these catalyze?

A

viral protein cleavage into functional units

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what is closure facilitated by to allow the virus to bud off from the cd4 cell?

A

specific contractile proteins that draw the neck together

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

p655 summary of hiv1 life cycle

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what are NRTIS?

A

nucleoside reverse transcriptase inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

How do nucleoside reverse transcriptase inhibitors work?

A

Prevents viral replication.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

NRTIS are incorporated into dna chains and act as X to prevent replication?

A

chain terminators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

How do non-nucleoside reverse transcriptase inhibitors work? NNRTIs

A

bind to and block HIV reverse transcriptase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

How do integrase inhibitors work?

A

Prevents viral DNA being integrated with the host cellular DNA
fast reductions in HIV viral load

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

How do protease inhibitors work?

A

Prevents processing and packaging of viruses before release from the lymphocyte.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

what does success of HIV relate to?

A

enormous viral replicative capacity (new gen per 1-4 hrs)

each gen archived in memory cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Why do viruses not produce identical replicas?

A

Reverse transcriptase is very error prone and lacks a proof-reading function.

slight mutations causes new viral cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

what allows real-time evolution of viral cells to changing environmental pressures in the host?

A

mutated viral replicas are archived in memory cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

what are the 3 types of mutations?

A

neutral

deleterious

advantageous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

whats a codon?

A

3 bases = 1 aa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

the evoluation of an advantageous virus is a process of selection under what pressure?

A

environmental
eg BP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

we take plasma virions to test for hiv, what is the half life?

A

6hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

true or false primary infection (PHI) involves 1 or 2 genetic types?

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

majority of virions are produced via which pool?

A

productively infected

activated CD4 lymphocytes
t1/2 2.2 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

follicular DC t1/2?

A

14 days (longer)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

virus gets incorporated into cells DNA but dont become activated + can become dormant and cause extremely long lived popns with extrememly long…

A

t1/2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

what is meant by viral quasispecies?

A

multiple rounds of replication, viral genetic errors, (due to absence of proof reading)
VQ = daughter viruses genetically distinct, archived in memory cells, portfolio of thousands of genetically related viruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

in acute infection is the viral population homogenous or heterogenous?

A

homogeneous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

in established infection is the viral population homogenous or heterogenous?

A

heterogeneous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

every single mutation that can cause drug resistance alr pre-exists in a chronically infected px
T/F?

A

True

we give drugs not fully suppressive to select out those mutations alr present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

over time as genetic diversity increases, how does VL viral load change?

A

decreases

high diversity, low VL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

What are the 3 main pathways to persistent viral replication then -> drug failure in HIV?

A

drug resistance

sub-inhibitory drug levels

host immune failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

On what two bases can drug resistance occur in patients?

A

pre-exists

selected by drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

give 2 ways that drug resistant varients can pre exist in patients?

A

transmitted or drug independent evolution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

how does persistant viral replication lead to drug failure?

A

evolution of drug resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

name 2 factors that lead to sub inhibitory drug levels?

A

pharmacological issues
or poor adherence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

2 types of selected drug resistance, regarding virus

A

selected or transmitted drug resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

what is meant by wt virus?

A

no drug resistant mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

outline how selected drug resistance works and can be lead to an emergence of wt virus after discontinuing therapy?

A

initial wt virus -> resistant variants selected during therapy -> rapid reemergence of wt virus upon discontinuing therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

in selected drug resistance - with continued presence of drugs, the resistant variant (WT) become what?

A

dominant quasispecies

->reemergence of WT virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

How can transmitted drug resistant cells be treated by drug?

A

upon reversion back to wild type virus.

57
Q

outline how transmitted drug resistance works and can lead to the reversion of wt virus?

A

initial drug resistant virus, slow reversion to wt virus due to error prone replicative mutations

58
Q

what information can you gather from a patient that is M184V in reverse transcriptase gene?

A

m exchanged for v, becomes mutant virus, resistant to 3tc drug so not effective

Methionine = WT = 3TC sensitive :)
Valine = mutant = 3TC resistant :(

59
Q

T/F
wt virus is the one that is best adapted to living in the host?

A

true
dominant and fittest virus

60
Q

why is resistance an important factor to consider ?

A

treatment starts earlier and lieflong,
resistance = limited treatment options,
difficult to treat,
greater cost of care,
premature virological failure

61
Q

what is the cause of AIDS?

A

HIV

62
Q

Antiviral drugs + tretament…

What is the goal of HIV treatment? 2

A

suppress viral replication

allow CD4 counts to recover

63
Q

What is 1st line treatment of HIV?

A

2 nucleoside analogues + NNRTI/Boosted protease inhibitor

64
Q

how long can clinical latency last?

A

6 months to 10 years

65
Q

what is seen in HIV rna copies and cd4 t lymphocyte count during primary infection?

A

immediate fall in cd4 t lymph

rapid increase in hiv rna

66
Q

natural history of HIV IS w/out treatment, after a while what opportunistic infections are seen?

A

thrush (direct link to low CD4)
oral hairy leukoplakia
TB
..
…

67
Q

damage and destruction of cd4 cells can allow for opportunistic infections, if this is not controlled what does the body do?

A

immune response to allow cd count to recover

68
Q

why is HIV testing important?

A

saves lives!!

69
Q

where are NRTIs active? nuceloside reverse transcriptase inhibitors

A

reverse transcriptase enzyme

70
Q

what is maraviroc an example of (drug class)?

A

CCR5 blocker

71
Q

AZT, ABC, 3TC are examples of…

A

NRTIs

72
Q

ATV, LPV, DRV are examples of…

A

PIs

73
Q

goal of HIV treatment?

A

drive HIV VL (RNA) to undetectable levels
and maintain lifelong viral suppression

74
Q

we aim for undetectable limits by x months since diagnosis?

A

6

75
Q

true or false: if patients are not undetectable by 6 months it is considered treatment failure?

A

true

76
Q

what is the limit of detection below in c/ml to be classed undetectable?

A

40

77
Q

if viral levels rebound greater than 1000 what assay can be performed to look for development of resistance?

A

genotypic assay

78
Q

the goal of treatment is to allow the x counts to recover, rebuild the x system and protect the individual?

A

CD4, immune

79
Q

what are the first line treatment options that are comprised of potent combination anti retroviral therapy?

A

2 NRTIs + integrase inhibitor/ nnrti/ boosted protease inhibitor

80
Q

list some reasons why intregrase inhibitors have come to the forefront of treatment?

A

potency, lack of ddis, robust towards resistance, lack of long term side effects

81
Q

give one benefit of single tablet regimes?

A

increased adherence

82
Q

give 2 ways by which the development of virological failure and resistance can be avoided?

A

maximising drug adherence and full persistant viral suppression

83
Q

can resistance develop if there is no viral replication, yes or no?

A

no
(cant select out viral resistant variants)

84
Q

can resistance develop is there is no selective pressure such as drug?

A

no
(to select out those resistant viruses)

85
Q

what is meant by ic50 in the context of hiv treatment?

A

conc of drug required to suppress in vitro viral replication by 50%

86
Q

What happens to the IC50 of a drug with resistant viruses?

A

Increases

causes 10 fold increase in drug conc needed to suppress hence increased resistance

87
Q

what measure is used as a measure for resistance?

A

IC50

88
Q

how does IC50 curve change for resistant virus w mutation X=100ng/ml.
as compared to original curve for WT virus? ie no mutations = 10ng/ml?

A

shift to right
resistant IC50 = higher i.e. need more drug to overcome resistance

89
Q

true or false: viral resistance is a relative phenomenon?

A

true
not all or nothing

90
Q

if someone is failing on an HIV drug and have on going viral replication, why will you continue to get resistance?

A

yes and virus will accquire more mutations whichll make virus more resistant

91
Q

with single -> double -> triple mutant, does resistance increase/ decrease?

A

increase

92
Q

T/F
v large intra px variability in metabolism of HIV drugs

A

true

93
Q

what is the term given to the flexibility to miss a dose without virological failure?

A

forgiveness

94
Q

What is forgiveness in HIV?

A

The flexibility to miss doses without virological failure.

95
Q

Examples of factors affecting pharmacological forgiveness?

A

How long drugs remain above the MEC.

Half-life dependent

96
Q

Examples of factors affecting virological forgiveness?

A

genetic barrier to resistance.

97
Q

what term describes how long drugs remain above the MEC?

A

pharmacological forgiveness

98
Q

what pk parameter is pharmacological forgiveness dependant on?

A

half life

99
Q

virological forgiveness is related to the genetic barrier of resistance, what does this mean?

A

how many mutations does a virus need to acquire until drugs no longer effective

100
Q

both pharmacological and virological forgiveness depend on presence of what?

A

viral replication in presence of drug

101
Q

why is stopping antiviral drugs not recommended?

A

increases risk of opportunistic HIV events eg MI -> most likely due to release of inflamm. mediators on stopping therapy

102
Q

do boosted protease inhibitors and some integrase inhibitors have higher or lower genetic barriers to resistance than some NRTIS?

A

higher

103
Q

what is meant by higher genetic barrier to resistance in terms of mutations?

A

multiple mutations have to be acquired before virus is resistant to treatment

104
Q

list some of the factors that genetic barrier to resistance is dependant on?

A

The effect of mutation on drug resistance.

Number of mutations required to cause resistance

impact of mutation of viral fitness

105
Q

low genetic barrier drugs often require how many mutations to cause high level resistance?

A

1

106
Q

What will happen if you continue to use a drug in the presence of a HIV virus-carrying mutations?

A

more mutations occur which makes the virus fitter and more resistant

107
Q

in the case of low genetic barrier drugs does resistance develop rapidly or slowly in the prescence of viral replication?

A

rapidly

108
Q

would it be appropriate to use a low genetic barrier drug as monotherapy in patients where replication is not fully suppressed? yes or no

A

NO

109
Q

do high genetic barrier drugs develop resistance mutations slowly or quickly, even when used as monotherapy?

A

slowly

110
Q

What type of drug would you not want to use as monotherapy?

A

drug with a low genetic barrier to resistance

111
Q

true or false, single mutations in high genetic barrier drugs may only cause low level resistance?

A

true

112
Q

are high or low genetic barrier drugs more likely to require an accumulation of mutations before high level resistance occurs and are generally more forgiving in the case of non adherence?

A

high genetic barrier drugs

113
Q

how can low genetic barrier drugs be protected by virological failure?

A

used in combination with high genetic barrier drugs

eg atripla

114
Q

What can cause sub-therapeutic levels of HIV drugs?

A

enzyme induction

115
Q

what enzyme is induced the most by HIV drugs?

A

cyp3a4

“boosting”

116
Q

what hiv drug is a common enzyme inducer/inhibitor?

A

RTV

117
Q

Effects of Efavirenz EFV on CYP3A4 enzymes when used with ATV?

A

EFV induces cyp3a4, which increases ATV metabolism thu decreases ATV conc

118
Q

what enzyme is induced and inhibited by RTV?

A

CYP3A4

119
Q

What is the principle of pharmaco-enhancement - boosting?

A

To administer low, therapeutic doses of a drug to inhibit metabolising enzymes and transport molecules and thereby reduce first pass loss and or clearance.

120
Q

what effect does boosting have on the following parameters,

peak conc,
AUC,
Cl,
half life,
Cmin

A

increase,
increase,
decrease,
increase or decrease,
usually increase

121
Q

name 2 boosters that are commonly used in HIV, to boost the plasma levels of anti retrovirals?

A

Cobicistat

Ritonavir

122
Q

higher Cmin of atazanavir + ritanovir allowing for moroe what?

A

forgiveness for late/ missed dose

123
Q

the predominant MoA of Cobi and RTV is to inhibit which 2 enzymes?

A

CYP3A4
CYP2D6

124
Q

What METABOLIC mechanisms cause DDIs with HIV drugs?

A

inhibition/induction of hepatic enzymes or transporters.

125
Q

What ABSORPTION mechanisms cause DDIs with HIV drugs?

A

inhibition/induction of intestinal enzymes or transporters

gastric pH

mineral supplements

126
Q

What EXCRETION-related mechanisms cause DDIs with HIV drugs?

A

inhibition of renal drug transporters

127
Q

for each drug involved what things should you think about when identifying DDIs?

A

metabolism renal/hepatic,
is it an inducer/inhibitor,
is it a substrate for metabolising enzymes or for specific drug transporters,
does it inhibit or enhance transporter function,
degree of protein binding

128
Q

total Cl of drug = what 2 types of Cl combined?

A

hepatic + renal Cl

129
Q

usually if a person has impaired liver functions, are hiv art drug levels higher or lower?

A

higher as will spend more time there

130
Q

are the majority of hiv drugs cleared by the liver or the kidneys?

A

liver
hepatic

131
Q

DDIs can -> over or under exposure of the antiviral or co admin medicine.
What is the consequence of this to the patient? 2

A

reduced clinical effectiveness of either medication
or
increased chance of AEs

132
Q

perpetrator-victim model of DDIs, what are the 4 possible consequences?

A

AEs or loss of efficacy of either HIV drug or co-med

133
Q

What drugs have high DDI potential?

A

Boosted PIs

EVG/cobi

efavirenz/nevirapine/etravirine

134
Q

What drugs have moderate DDI potential?

A

Rilpivirine

Maraviroc

Doravirine

(all victims of enzyme inhib and induction)

135
Q

What drugs have low DDI potential?

A

Raltegravir

Most NRTIs

Dolutegravir/bictegravir

136
Q

What co-morbidities in HIV commonly emerge?

A

Renal dysfunction

Cardiovascular disease

Osteoporosis

cancer

137
Q

What is the risk of sexual transmission from +ve partner on successful ART treatment to a -ve partner having regular unprotected sex over a 5 year period?

A

0!

138
Q

whats U=U?

A

when ART now so effective, px treated amd have undetectable VL (<200 copies) have lvls of virus that are untransmittable even in USI

Health 32 (11 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions